Resultados da pesquisa - Norman J. Lacayo

Refinar resultados
  1. 1
    A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury

    A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury Por Shelli R. Kesler, Norman J. Lacayo, Booil Jo

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types

    Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types Por Julia Salzman, Charles Gawad, Peter Lincoln Wang, Norman J. Lacayo, Patrick O. Brown

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia

    Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia Por Thomas Alexander, Norman J. Lacayo, John Choi, Raul C. Ribeiro, Ching‐Hon Pui, Jeffrey E. Rubnitz

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to Cyclosporins

    Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to Cyclosporins Por Kevin G. Chen, George E. Durán, Katherine A. Steger, Norman J. Lacayo, Jean‐Pierre Jaffrézou, Charles Dumontet, Branimir I. Šikić

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Altered resting state functional connectivity in young survivors of acute lymphoblastic leukemia

    Altered resting state functional connectivity in young survivors of acute lymphoblastic leukemia Por Shelli R. Kesler, Meike Gugel, Mika Pritchard‐Berman, Clement Lee, Emily C. Kutner, S. M. Hadi Hosseini, Gary V. Dahl, Norman J. Lacayo

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia

    Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia Por Charles Gawad, François Pépin, Victoria Carlton, Mark Klinger, Aaron C. Logan, David B. Miklos, Malek Faham, Gary V. Dahl, Norman J. Lacayo

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    The incidence and clinical significance of nucleophosmin mutations in childhood AML

    The incidence and clinical significance of nucleophosmin mutations in childhood AML Por Patrick A. Brown, Emily McIntyre, Rachel E. Rau, Soheil Meshinchi, Norman J. Lacayo, Gary V. Dahl, Todd A. Alonzo, Myron Chang, R.J. Arceci, Donald Small

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin

    AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin Por David B. Rosen, Kimberly H. Harrington, James Cordeiro, Ling Y. Leung, Santosh Putta, Norman J. Lacayo, George S. Laszlo, Chelsea J. Gudgeon, Donna E. Hogge, Rachael E. Hawtin, Alessandra Cesano, Roland B. Walter

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children’s Oncology Group Study POG 9421

    Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children’s Oncology Group Study POG 9421... Por Maureen M. O’Brien, Xueyuan Cao, Stanley Pounds, Gary V. Dahl, Susana C. Raimondi, Norman J. Lacayo, Jeffrey W. Taub, M N Chang, Howard J. Weinstein, Yaddanapudi Ravindranath, Hiroto Inaba, Dario Campana, Ching‐Hon Pui, Jeffrey E. Rubnitz

    Publicado em 2012
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  10. 10
    Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse

    Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse Por Zinaida Good, Jolanda Sarno, Astraea Jager, Nikolay Samusik, Nima Aghaeepour, Erin F. Simonds, Leah White, Norman J. Lacayo, Wendy J. Fantl, Grazia Fazio, Giuseppe Gaipa, Andrea Biondi, Robert Tibshirani, Sean C. Bendall, Garry P. Nolan, Kara L. Davis

    Publicado em 2018
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Delayed cancer diagnoses and high mortality in children during the COVID‐19 pandemic

    Delayed cancer diagnoses and high mortality in children during the COVID‐19 pandemic Por Yangyang Ding, Sneha Ramakrishna, Adrienne H. Long, Charles Phillips, Raúl Montiel-Esparza, Caroline Diorio, L. Charles Bailey, Shannon L. Maude, Richard Aplenc, Vandana Batra, Anne F. Reilly, Susan R. Rheingold, Norman J. Lacayo, Kathleen M. Sakamoto, Stephen P. Hunger

    Publicado em 2020
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  12. 12
    A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia

    A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia Por Rosa Nguyen, Huiyun Wu, Stanley Pounds, Hiroto Inaba, Raul C. Ribeiro, David Cullins, Barbara Rooney, Teresa M. Bell, Norman J. Lacayo, Kenneth Heym, Barbara Degar, Deborah Schiff, William E. Janssen, Brandon M. Triplett, Ching‐Hon Pui, Wing Leung, Jeffrey E. Rubnitz

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes

    Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes Por Norman J. Lacayo, Soheil Meshinchi, Paı̈vi Kinnunen, Ron Yu, Yan Wang, Christianna M. Stuber, Lorrie Douglas, Romina Wahab, David L. Becton, Howard J. Weinstein, Myron Chang, Cheryl L. Willman, Jerald P. Radich, Robert Tibshirani, Yaddanapudi Ravindranath, Branimir I. Šikić, Gary V. Dahl

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

    Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial Por Jeffrey W. Taub, Jason N. Berman, Johann Hitzler, April Sorrell, Norman J. Lacayo, Kelley Mast, David Head, Susana C. Raimondi, Betsy Hirsch, Yubin Ge, Robert B. Gerbing, Yi-Cheng Wang, Todd A. Alonzo, Dario Campana, Elaine Coustan‐Smith, Prasad Mathew, Alan S. Gamis

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

    Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study Por Seth E. Karol, Thomas Alexander, Amit Budhraja, Stanley Pounds, Kristin Canavera, Lei Wang, Joshua Wolf, Jeffery M. Klco, Paul E. Mead, Soumyasri Das Gupta, Su Y. Kim, Ahmed Hamed Salem, Tammy L. Palenski, Norman J. Lacayo, Ching‐Hon Pui, Joseph T. Opferman, Jeffrey E. Rubnitz

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

    Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia Por Caroline Duault, Anil Kumar, Adeleh Taghi Khani, Sung June Lee, Lu Yang, Min Huang, Christian Hurtz, Bryan Manning, Lucy Ghoda, Tinisha McDonald, Norman J. Lacayo, Kathleen M. Sakamoto, Martin Carroll, Sarah K. Tasian, Guido Marcucci, Jianhua Yu, Michael A. Caligiuri, Holden T. Maecker, Srividya Swaminathan

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial

    Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial Por Jeffrey E. Rubnitz, Norman J. Lacayo, Hiroto Inaba, Kenneth Heym, Raul C. Ribeiro, Jeffrey W. Taub, Jennifer L. McNeer, Barbara Degar, Deborah Schiff, Allen Eng Juh Yeoh, Elaine Coustan‐Smith, Lei Wang, Brandon M. Triplett, Susana C. Raimondi, Jeffery M. Klco, John Choi, Stanley Pounds, Ching‐Hon Pui

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

    Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial Por Jeffrey E. Rubnitz, Hiroto Inaba, Gary V. Dahl, Raul C. Ribeiro, W. Paul Bowman, Jeffrey W. Taub, Stanley Pounds, Bassem I. Razzouk, Norman J. Lacayo, Xueyuan Cao, Soheil Meshinchi, Barbara Degar, Gladstone Airewele, Susana C. Raimondi, Mihaela Onciu, Elaine Coustan‐Smith, James R. Downing, Wing Leung, Ching‐Hon Pui, Dario Campana

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells

    Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells Por Bryan Mitton, Hee‐Don Chae, Katie Hsu, Ritika Dutta, Grace Aldana-Masangkay, Roberto Ferrari, Kara L. Davis, Bruce Tiu, Arya Kaul, Norman J. Lacayo, Gary V. Dahl, Fang Xie, B X Li, Marcus R. Breese, Elliot M. Landaw, Garry P. Nolan, Matteo Pellegrini, Serguei R. Romanov, Xiangshu Xiao, Kathleen M. Sakamoto

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL

    Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL Por Yuxuan Liu, Haowen Jiang, Jingjing Liu, Lucille Stuani, Milton Merchant, Astraea Jager, Abhishek Koladiya, Ti‐Cheng Chang, Pablo Domizi, Jolanda Sarno, Tim Keyes, Dorra Jedoui, Ao Wang, Jie Meng, Felix J. Hartmann, Sean C. Bendall, Min Huang, Norman J. Lacayo, Kathleen M. Sakamoto, Charles G. Mullighan, Loh Mignon, Jiyang Yu, Jun J. Yang, Jiangbin Ye, Kara L. Davis

    Publicado em 2025
    Obter o texto integral
    Pré-impressão
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: